Zhengye Biotechnology Holding (ZYBT) Short-term Investments (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Short-term Investments for 3 consecutive years, with $281.99 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Short-term Investments rose 1.28% year-over-year to $281.99 in Q4 2025; TTM through Dec 2025 was $281.99, a 1.28% increase from a year earlier, with the FY2025 full-year figure at $223000.0, up 13.2% from the prior year.
• Short-term Investments was $281.99 for Q4 2025 at Zhengye Biotechnology Holding, down from $282000.0 in the prior quarter.
• Over five years, Short-term Investments peaked at $1.7 million in Q4 2023 and troughed at $278.43 in Q4 2024.
• A 3-year average of $491225.9 and a median of $141141.0 in 2025 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments tumbled 99.98% in 2024 and gained 1.28% in 2025, its largest moves.
• Over 3 years, Short-term Investments stood at $1.7 million in 2023, then plunged by 99.98% to $278.43 in 2024, then advanced by 1.28% to $281.99 in 2025.
• The last three Short-term Investments figures came in at $281.99 (Q4 2025), $282000.0 (Q2 2025), and $278.43 (Q4 2024), per Business Quant data.